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Abstract
The enveloped morbilliviruses utilise conserved proteinaceous receptors to enter host cells: SLAMF1 or Nectin-4. Receptor 
binding is initiated by the viral attachment protein Haemagglutinin (H), with the viral Fusion protein (F) driving membrane 
fusion. Crystal structures of the prototypic morbillivirus measles virus H with either SLAMF1 or Nectin-4 are available and have 
served as the basis for improved understanding of this interaction. However, whether these interactions remain conserved 
throughout the morbillivirus genus requires further characterisation. Using a random mutagenesis approach, based on error- 
prone PCR, we targeted the putative receptor binding site for SLAMF1 interaction on peste des petits ruminants virus (PPRV) H, 
identifying mutations that inhibited virus- induced cell- cell fusion. These data, combined with structural modelling of the PPRV 
H and ovine SLAMF1 interaction, indicate this region is functionally conserved across all morbilliviruses. Error- prone PCR pro-
vides a powerful tool for functionally characterising functional domains within viral proteins.
The morbilliviruses are a conserved group of pathogens that 
infect mammals. The prototypic virus measles virus (MeV) 
has a well- established human tropism, while other viruses 
infect small ruminants (peste des petits ruminants, PPRV), 
carnivores (canine distemper virus, CDV), aquatic mammals 
(porcine distemper virus, PDV, and cetacean morbillivirus, 
CeMV) and cattle (the now eradicated rinderpest virus, RPV). 
A characteristic feature of these viruses is their conserved 
usage of proteinaceous receptors, SLAMF1 or Nectin-4, to 
enter cells, respectively. SLAMF1, identified in 2000 [1] is 
expressed on immune cells, including specific subsets of T 
and B cells as well as macrophages and dendritic cells, with 
infection contributing to leucopoenia and immunosuppres-
sion. Nectin-4, independently identified by two laboratories 
in 2011 [2, 3], is a component of the adherens junction on 
polarised epithelial cells, and expressed in the nasopharynx, 
trachea and various other tissues [4]. The dual- tropism of 
morbilliviruses for these specific receptors is now understood 
to contribute to their significant pathogenicity and efficient 
onward transmission [2] and the mechanistic processes 
underpinning the entry of morbilliviruses is now relatively 
well characterised. In a multi- step process the tetrameric 
viral Haemagglutinin protein (H), a type II membrane gly-
coprotein, embedded in the viral membrane attaches to these 
cellular receptors via the globular head of its ectodomain, 
found at the C terminus of the polypeptide [5]. Such bind-
ing triggers conformational changes in these head domains, 
which through a process involving the four- helix bundle stalk 
(N- terminal; amino acids 59–154) of H, ultimately activates 
the trimeric, proteolytically pre- processed, viral Fusion pro-
tein (F), a type I membrane glycoprotein, leading to unfolding 
of this oligomer and insertion of the fusion peptide in the 
plasma membrane [6]. Similar processes occur during both 
viral- cell fusion and cell- cell fusion, the major routes of mor-
billivirus entry into cells. Recent work by our lab and others 
in the field has highlighted how the specificity of this receptor 
usage may influence the host- range of individual viruses. This 
has been led by experimental identification of mutations that 
confer additional receptor tropisms (D540G in CDV H [7]) 
as well as structure- guided approaches to identify similar 
restrictions (R191P in PPRV H [8]), mutations which are both 
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proteins. However, many of the structural conclusions drawn 
from this work are based on assumptions that the RBD of all 
morbillivirus H proteins is structurally similar to the com-
plex solved for MeV H and marmoset SLAM (maSLAM) [9], 
despite evidence that there may be subtle differences in the 
interaction site [10]. Our initial aim with this study was to 
use an unbiased mutagenic screening approach to confirm 
the importance of this proposed RBD of PPRV H for binding 
to the receptor SLAMF1.
More generally, however, we were also interested in devel-
oping tools that provide alternatives to classical gain of func-
tion experiments, i.e. the forced adaptation of morbilliviruses 
to non- cognate receptors followed by genome sequencing to 
identify mutations associated with phenotypic changes in 
receptor usage, an approach safely and successfully applied 
by other laboratories [7]. Previously, we have used a process of 
informed mutagenesis, based on structure- guided modelling 
to predict the role of specific amino acids in host- receptor 
tropism [8]. However, this approach has its limitations and 
does not recapitulate the random mutagenesis and natural 
selection process that RNA viruses use to rapidly evolve when 
under bottleneck selection. To this end we devised a protocol 
to randomly mutagenize the proposed RBD.
The structure of MeV H bound to SLAMF1 was solved in 
2011, identifying four key motifs within a large receptor 
binding domain (RBD) in the globular head with a contact 
area of 1050 Å2 [9]. The majority of the RBD for SLAMF1 lies 
within the C terminus of the H polypeptide, corresponding 
to β-propellers 5 and 6, and is composed of hydrophobic 
interactions and salt bridges (sites 1, 2 and 4) as well as 
intermolecular β-sheet interactions (site 3) between H and 
SLAMF1. Although site 3 is in close proximity to sites 1, 2 
and 4 (aa 505–554), this β-sheet (aa 191–195) is distal on the 
polypeptide, closer to the stalk and its linker domain [5, 9, 11]. 
This RBD overlaps to some degree with the site of Nectin-4 
interaction which lies in a groove between propellers 4 and 
5 [6, 12]. Interestingly, receptor binding on the side of the 
morbillivirus H β-barrel contrasts with related paramyxovi-
ruses such as human parainfluenza 3 (HPIV3; a respirovirus) 
and Hendra virus (HeV; a henipavirus) where receptor recog-
nition is localised to the central cavity (reviewed in detail 
in Navaratnarajah et al. [6]). Our own work mutating key 
residues in the RBD (specifically position 191 within the 
intermolecular β-sheet interaction of site 3 [8, 9]), together 
with modelling of this interaction, indicates that the PPRV 
and ovine (sheep) SLAMF1 RBD is likely to be structur-
ally similar, and important in determining host- range ([8], 
Fig. 1a). To functionally screen the importance of this region 
in PPRV we adopted a random mutagenesis approach driven 
by error prone PCR (epPCR) (described in detail in [13]), 
targeting a PPRV H cloned from a field isolate of this virus 
(AJ849636 [14]). Using this approach, a library of increasingly 
mutagenized PCR products was generated, analogous to the 
process of forcibly driving RNA virus populations towards 
error catastrophe with chemical mutagens such as favip-
iravir (Fig. 1b) [15]. To focus our mutagenesis on the PPRV 
H RBD we combined this approach with an overlap PCR 
amplification protocol to generate a library of PCR products 
with a ‘faithful’ N terminus and a mutagenized C terminus 
(Fig. 1c). Of note, this approach did not therefore target site 
3 of the RBD, or the stalk and its linker, for mutagenesis 
since they are, as discussed earlier, distal on the polypeptide. 
In total 64 cycles of epPCR were performed with nascent 
product moved to a new tube every four cycles (as described 
in [13]), yielding 16 products with an increasingly complex 
mix of mutagenized DNA (Fig. S1a, available in the online 
version of this article). To minimise downstream handling 
the epPCR products were then pooled into four libraries (1–4, 
5–8, 9–12 and 13–16), with the range representing the epPCR 
products, before being used as templates for generation of 
full- length DNA products by standard PCR (L1-4, L5-8, 
L9-12 and L13-16; Fig. S1b). A ‘faithful’ wild- type H sequence 
(WT) was also amplified as a positive control. All products 
were amplified with primers containing an N- terminal T7 
promoter sequence and restriction enzyme sites for cloning. 
To validate our hypothesis that random mutagenesis of 
PPRV H would lead to a loss of binding to ovine SLAMF1 
we examined the capacity of these libraries to drive cell- cell 
fusion in transfected cells (described in Fig. 1d). HEK293T 
effector cells, initially infected with a recombinant fowlpox 
virus expressing T7 polymerase, were transfected with 
H- expressing PCR products, as well as plasmids expressing 
PPRV F and one- half of a split GFP- Luciferase reporter 
(rLuc- GFP 1–7 [16]). Separately, HEK293T target cells were 
transfected with plasmids expressing ovine SLAMF1 and the 
other half of the reporter (rLuc- GFP 8–11). Whereas the WT 
PCR product generated a robust level of cell- cell fusion, the 
epPCR libraries, as expected, showed decreasing levels of 
fusion as the epPCR cycle number increased. Indeed, effector 
cells expressing library L13-16 did not show levels of fusion 
above those seen with the negative control target cells bearing 
no receptor (Fig. 1e).
To identify and characterise individual mutants we adopted 
a stepwise screening procedure involving the cloning of 
the epPCR PPRV H libraries into an expression vector 
(pcDNA3.1) and the subsequent examination of cell- cell 
fusion in a plasmid- transfection based system that does not 
require recombinant fowlpox virus [8]. To facilitate screening, 
we initially generated pools containing 16 individual colonies, 
with three pools per library (denoted A to C for each of the 
four epPCR libraries, Fig. 2a). Screening of the pools (L1- 4A 
through L13- 16C, where each contains 16 constructs) indi-
cated that the first library (pools L1- 4A, L1- 4B and L1- 4C) 
had maintained approximately 50 % fusion activity (Fig. 2b). 
To avoid the characterisation of non- mutated (wild- type, 
WT) clones in library L1-4 we focused our screening on 
the subsequent libraries, where evidence of fusion was more 
sporadic, our goal being the identification of a mixture of 
functional and non- functional H proteins. Choosing the 
pools L5- 8A, L5- 8C and L13- 16B, where fusion activity was 
present (and discarding the rest where little evidence of fusion 
remained) we sub- divided each of these into four sub- pools 
for further characterisation (each containing four constructs), 
subsequently identifying four with functional phenotypes 
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Fig. 1. Error- prone PCR mutagenesis of PPRV H. (a) A model of ovine SLAM (oSLAM, blue ribbons) in complex with PPRV H (yellow and 
red ribbons), generated using the structure of MeV H in complex with marmoset SLAM (PDB ID 3ALX [9]) is shown in two orthogonal 
views. In the right- hand view the molecular surface of PPRV H is shown. Residues that were mutagenized by epPCR are coloured 
red. Model available at https://doi.org/10.17863/CAM.58532. (b) A simplified schematic of epPCR illustrating the correlation between 
increasing cycle number and the number of mutations (red crosses). (c) epPCR libraries of the PPRV H ORF were generated using Taq 
polymerase (Promega), as described in [13] with a 3′ primer including a NotI restriction site, and 64 cycles yielded 16 PCR products in 
total (represented by red bar; see Fig. S1a). These were subsequently pooled into four libraries (1–4, 5–8, 9–12 and 13–16; see Fig. S1b). 
Seperately, a faithful PCR copy of the N terminus (yellow) was amplified by standard high- fidelity PCR (using Kod polymerase, Merck) with 
a 5′ primer containing a T7 promoter sequence (green) and the NheI restriction site (blue). Lastly, overlap PCR was performed using the 
two external primers and Kod high- fidelity PCR to generate four libraries containing PCR products with full- length PPRV ORFs (yellow/
red, L1-4, L5-8, L9-12 and L13-16 see Fig. S1b). (d) The quantifiable cell- cell fusion for PPRV relies on co- transfection of effector cells 
[E] with constructs expressing PPRV F and H proteins as well as half of a rLuc- GFP dual reporter [16]. These are co- cultured with target 
cells [T] expressing ovine SLAM and the corresponding half of the reporter. A cognate combination of FH and receptor leads to cell- cell 
fusion, reconstitution of the reporter and activation of the luciferase and GFP proteins. (e) Increasing epPCR mutagenesis of the PPRV 
H protein leads to reduced cell- cell fusion. Effector cells were transfected with the split reporter and no glycoprotein (No GP), plasmids 
bearing WT PPRV F and H (Plasmid), a plasmid expressing F and a PCR product expressing the PPRV H ORF (WT) amplified using the 
same external primers used in (c), or, the overlapped PCR products from this same epPCR protocol. After 2 days these were co- cultured 
with target cells expressing the corresponding half of the split reporter and either mock vector (No receptor) or a plasmid expressing 
ovine SLAMF1 (Ovine SLAM). Luciferase activity was measured using a cell permeable Renilla luciferase substrate (Coelenterazine) the 
following day. Assays were performed in biological triplicate with the mean and standard deviation plotted.
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Fig. 2. Screening of PPRV H epPCR libraries to identify individual mutants and link phenotype to genotype. (a) The pool selection and 
deconvolution strategy for identifying individual H mutants with modified cell- cell fusion activity (see main text for detailed explanation). 
(b) Screening of the pools L1- 4A to L13-16- C (each containing 16 colonies) using a PPRV cell- cell fusion assay, as described in Fig. 1, 
identified a correlation between increased epPCR cycle number and decreased cell- cell fusion activity (similar to Fig. 1e). For WT a 
selection of colonies expressing the unmutated PPRV H was used (n=8 or as shown). (c) Pools L5- 8A, L5- 8C and L13- 16B were taken 
forward for further analysis by sub- dividing the pools into four colonies per pool (e.g. L5- 8A/1 to L5- 8A/4) and re- examining their 
cell- cell fusion phenotype. (d, e) Based on these results pools L5- 8A/1, L5- 8C/2, L5- 8C/3 and L13- 16B/4 were separated into their 
individual colonies, re- screened in the cell- cell fusion assay and each mutant’s PPRV H ORF sequenced between nt 1335 and 1808 – 
the region targeted by epPCR – with any mutations to the PPRV H amino acid sequence calculated. Clone numbers in (e) are coloured 
based on mutation type and relative activity in the cell- cell assay (green=high activity relative to WT, orange=frameshift or premature 
stop codon, red=little or no activity relative to WT). Luciferase activity was measured using a cell permeable Renilla luciferase substrate 
(Coelenterazine). Assays were performed in biological triplicate with the mean and standard deviation plotted. Experiments in panel D 
were performed three separate times with a representative data set shown.
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(Fig. 2c; L5- 8A/1, L5- 8C/2, L5- 8C/3 and L13- 16B/4). At this 
final stage we then characterised and sequenced all individual 
mutants in these sub- pools (16 constructs sequenced in total), 
identifying four that had retained robust activity in the cell- 
cell fusion assay (L5- 8A/1A, L5- 8C/2D, L5- 8C/3D and L13- 
16B/4A) (Fig. 2d, e; green text). Of note, at each step the pools 
(and finally individual clones) were analysed by restriction 
digest to confirm the insertion of the H ORF (Fig. S1c–e).
The four functional mutants had a combination of genotypes 
including two with WT amino acid (aa) sequences, a single 
mutant with the mutations M479T/I498V/I508N/V515A/
D530E and another with R556Q/H575Y. That L5- 8A/1A 
expressed a WT PPRV H aa sequence was perhaps not 
surprising, given the relatively low number of associated 
epPCR amplification cycles (20-32); however, the presence 
of a similar genotype in L13- 16B/4A was more interesting. 
In this case the related cycle number is much higher (52-64) 
indicating that, even at the final stages of the epPCR process, 
WT PCR products exist within the population. Neverthe-
less, by identifying mutant genotypes that sustained fusion 
the epPCR process had identified functional plasticity within 
PPRV H at specific aa residues. More detailed examination of 
these residues, informed by the modelled structure of PPRV 
H with oSLAM, provides some context for this maintenance 
of function (Fig. 3a). The I498V mutation in L5- 8C/2D, for 
example, is a surface exposed isoleucine which is close to the 
predicted oSLAM RBD; however, the conservative substitu-
tion to valine is unlikely to change the hydrophobicity of this 
region. Likewise, the V515A and D530E mutations, although 
buried in the protein interior, are conservative mutations 
unlikely to dramatically alter protein structure or function. 
In L5- 8C/3D the H575Y mutation reflects changes to a 
surface exposed residue distant from the RBD, with substitu-
tion to tyrosine likely to be well tolerated. Supporting this 
conclusion, amino acid alignments of MeV, RPV, CDV and 
PPRV H proteins show that this residue is highly variable 
Fig. 3. Examining the predicted structural configuration, electrophoretic mobility and glycosylation pattern of individual PPRV H mutants. 
(a, b) A model of ovine SLAM (oSLAM, blue ribbons) in complex with PPRV H (yellow ribbons) is shown in three orthogonal views. (a) 
Residues that could be mutated without abolishing PPRV H binding to oSLAM are shown in spacefill, coloured light green (L5- 8C/3D) 
or dark green (L5- 8C/2D). (b) Residues that prevented SLAM binding when mutated are shown in spacefill, coloured pink (L5- 8A/1C), 
magenta (L5- 8C/3B) or red (L13- 16B/4C). (c, d) Generation of individual point mutations present in L5- 8A/1C and L5- 8C/3B, and their 
characterisation in a PPRV cell- cell fusion assay, identified mutations H536L, L599P and I538N as being particularly deleterious to 
receptor usage. Assays were performed in biological quadruplicate with the mean and standard deviation plotted. Experiments were 
performed three times with a representative data set shown. (e) HEK293T cells were transfected with plasmids expressing the PPRV 
mutant (coloured as indicated in Fig. 2e) and lysates harvested at 24 h for Western blot with an antibody detecting the cytoplasmic tail 
(not targeted by epPCR) of PPRV H. GAPDH Westerns were included as protein loading controls. (f) The glycosylation of individual PPRV 
H mutants, or the WT H, was examined using Peptide: N- Glycosidase F (PNGaseF; New England Biolabs) as per the manufacturer’s 
instructions. Treated or untreated lysates were prepared and examined as per (c). * The band at 55 KDa in the PPRV H Western is a non- 
specific cellular protein.
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with glutamine, arginine and aspartic acid being found in 
MeV, RPV and CDV strains, respectively (data not shown). 
The R556Q mutation is interesting as this residue is more 
conserved in morbilliviruses (arginine in PPRV, MeV and 
CDV, and lysine in RPV) and closer to the RBD, specifically 
sites F552 and P554 – components of sites 2 and 4 in the MeV 
H RBD characterised by Hashiguchi et al. [9]. However, this 
residue does not form well- ordered salt bridges or hydrogen 
bonds in the MeV- maSLAM model [9]; perhaps explaining 
why the glutamine side chain is well- tolerated from a func-
tional perspective (Fig. 3a).
Another interesting consequence of the epPCR process was 
the introduction of a high proportion of stop codons, with six 
clones (38%) presumably losing cell- cell fusion functionality 
in this way (Fig. 2e; orange text). Of note, one of these mutants, 
L5- 8C/3C repeatedly showed activity in our assay (Fig. 2d); 
however, the subsequent re- isolation of six individual clones 
of this construct did not, indicating this activity was likely 
the result of contamination, possibly WT plasmid (data not 
shown). Elsewhere, two frameshifts were observed, the result 
of 1 nt deletions, both guanidines, highlighting the potential 
for this protocol to erroneously remove bases from the nascent 
strand (Fig. 2e; orange text). A final non- functional mutant 
lacking the epPCR- generated region of H was also identified 
(L13- 16B/4D); however, this is likely an artefact of cloning. In 
contrast, a number of full- length ORF- containing clones with 
little or no functionality in the cell- cell fusion assay were also 
identified; L5- 8A/1C (R450S/I467V/H536L/S548T/V555F/
F559S/L599P), L5- 8C/3B (G511R/I538N/L584R), and L13- 
16B/4C (S462T/N468I/V515F/P518L/Y529F/N558Y/L566Q/
H575R/N587Y/D591E/E593Q/E603G), respectively (Fig. 2d, 
e; red text), identifying aa sites in PPRV H where mutations 
are poorly tolerated. Examination of the location of these 
residues on our modelled interaction of PPRV H and oSLAM 
identified several substitutions likely to be responsible for the 
observed loss of function (Fig. 3b). Within L5- 8A/1C, the 
H536L substitution would prevent the formation of a side- 
chain H- bond with Y529, which may cause local structural 
rearrangements in the region close to the oSLAM binding 
site. In addition, substitution of the buried L599 residue with 
proline would probably cause significant structural rearrange-
ment of the H β-propeller number 5, since the constrained 
backbone conformation of proline (ϕ=−60°±20°) is not 
compatible with the phi angle adopted by L599 (ϕ=−131.6°). 
The specific deleterious role of H536L and L599P in the loss 
of function of clone L5- 8A/1C, in contrast to other changes 
including I467V, V555F and F559S, was confirmed by indi-
vidual point mutation of these residues in a WT PPRV H 
clone (Fig. 3c). With reference to L5- 8C/3B the I538N muta-
tion is close to predicted interaction motifs within the RBD 
[9] and introduction of a polar residue into this hydrophobic 
cavity is likely to be poorly tolerated, causing significant 
structural rearrangement. Again, the individual importance 
of this mutation was subsequently confirmed by standard 
targeted mutagenesis of the WT PPRV H clone (Fig. 3d). 
Lastly, within L13- 16B/4C four mutations (N468I, V515F, 
Y529F and L566Q) stand out as being particularly deleterious. 
N468 is a buried polar residue in proximity to RBD motifs 
thought to interact with oSLAM. Introduction of a non- polar 
residue at this site would prevent formation of hydrogen 
bonds with Y410, destabilising the local structure. Unlike 
the conservative V515A mutation found in the functional 
mutant L5- 8C/2D, the introduction of a large hydrophobic 
phenylalanine (V515F) is likely to cause disruption to the core 
folding of PPRV H. Furthermore, the Y529F change, leading 
to the loss of the terminal hydroxyl group of this side- chain, 
would prevent H- bonds forming with the O(carbonyl) of 
G561 and the side chain of H536, causing local disruption and 
likely affecting oSLAM binding. Finally, the L566Q mutation, 
leading to the substitution of a buried hydrophobic residue 
with glutamine, a polar amino acid, would again cause local 
disruption, although this is further from the SLAM interface 
and it is unclear how this might affect binding. In conclusion 
the mutants L5- 8A/1C, L5- 8C/3B and L13- 16B/4C are all 
predicted to have deleterious mutations leading to significant 
structural rearrangement of H and/or the oSLAM RBD, fitting 
with their considerable loss of function in cell- cell fusion 
assays.
Western blot of the proteins produced from each of these 
clones, using an antibody targeting the cytoplasmic tail of 
PPRV H (an epitope found at the N- terminus of the polypep-
tide and therefore not sensitive to mutation by epPCR), was 
also performed. This correlated well with the sequence infor-
mation and identified a number of interesting features of the 
H protein. Firstly, the introduction of premature stop codons 
or frameshifts (creating various C- terminal truncations) does 
not dramatically alter the relative stability of many of the 
polypeptides, with some being produced to near WT levels 
(Fig. 3e; orange text). Secondly, all the functional full- length 
mutants were expressed as two distinct bands on the Western 
blot with electrophoretic mobility corresponding to masses 
of ~70 kDa (Fig. 3e – green text), while the non- functional 
mutants either did not have the higher band (L5- 8A/1C and 
L5- 8C/3B) or were poorly expressed (L13- 16B/4C). One 
possible explanation for the lack of the higher molecular 
weight band in L5- 8A/1C and L5- 8C/3B is the loss of specific 
post- translational modifications to PPRV H. To examine this 
in more detail we performed PNGaseF treatment of these 
mutant Hs (L5- 8A/1C and L5- 8C/3B), comparing them to 
L5- 8C/2D, L5- 8C/3D and WT H. PNGaseF is an amidase, 
which cleaves between the innermost GlcNAc and asparagine 
residues of high mannose, hybrid, and complex oligosaccha-
rides and can remove almost all N- linked oligosaccharides 
from glycoproteins. Treatment with this enzyme reduced all 
H proteins to a uniform lower molecular weight, confirming 
glycosylation as the main determinant in the varying elec-
trophoretic mobility of the H proteins (Fig. 3f). However, in 
the untreated controls the two functional full length mutants 
(L5- 8C/2D and L5- 8C/3D) again migrated at a higher molec-
ular weight, with the two non- functional mutants (L5- 8A/1C 
and L5- 8C/3B) running at intermediate positions. We postu-
late that the upper band represents H proteins with more 
mature glycans, while the intermediate band may contain 
immature glycans, a consequence of protein misfolding. For 
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other mutants, for example L13- 16B/4C, the large number 
of structurally deleterious mutations (in particular N468I, 
V515F, Y529F and L566Q; discussed above) is likely to have 
affected overall protein stability, leading to degradation and 
the lower signal seen by immunoblotting.
Using a combination of epPCR and a relatively high throughput 
screening tool we were able to functionally characterise 
domains within the PPRV H protein proposed to contain 
the RBD. This included random mutagenesis of important 
residues for SLAMF1 interaction, e.g. D530E in L5- 8C/2D, 
which although absolutely conserved in morbilliviruses 
appeared well tolerated, as well as those in close proximity, 
e.g. V555F in L5- 8A/1C and R556Q in L5- 8C/3D. That PPRV 
H could tolerate the V555F change is perhaps not surprising 
as a phenylalanine at this position is actually more common 
in morbillivirus H proteins. In general, the identification of a 
number of non- functional yet full- length mutants supports 
our assumption that there is structural analogy between PPRV 
and MeV H, not surprising given the aa similarity of the two 
proteins (67 % conserved). A low number of conservative 
changes within the epPCR targeted region were reasonably 
well tolerated; however, as more significant structural changes 
were introduced, and the number of mutations increased, the 
functionality of the encoded proteins decreased. Inspection of 
our structural model suggests that the majority of deleterious 
mutations prevent SLAM binding by disrupting the fold of 
PPRV H, e.g. H536L and L599P in L5- 8A/1C (Fig. 3b, c) as 
well as H536L in L5- 8A/1C (Fig. 3b, d) consistent with predic-
tions that most disease- causing human SNPs affect protein 
stability [17]. Whilst our approach did not probe the role of 
the stalk domain of H (residues 59–154) it is worth noting 
that, post- receptor engagement, this domain is also important 
in triggering fusion, through its interactions with F. Although 
this region has been characterised in more detail for MeV 
[11, 18] a detailed mutational analysis of the stalk of PPRV 
H is also warranted.
Broader evaluation of the strengths of this epPCR approach 
can also be made. This technique is clearly useful when an 
associated 3D structure is available. Indeed, in our experi-
ments cross- referencing structural models with the results 
of our epPCR mutagenesis allowed detailed functional 
hypotheses to be developed and tested. However, epPCR 
generated more misfolding mutations, than mutations at the 
receptor- binding surface, in PPRV H. This, combined with 
the high frequency of stop codons inserted, might suggest 
site- directed mutagenesis, where more targeted mutations to 
the RBD is achievable, remains the preferred approach as well 
as more in- depth mutational scanning approaches recently 
established for SARS- CoV-2 spike protein [19]. The technique 
is also dependent on a tractable functional phenotypic screen, 
although this is true of all directed evolution approaches 
where random mutagenesis is applied to simulate natural 
rates of error. Nevertheless, epPCR could represent a very 
powerful starting point for viral proteins which are known to 
be intrinsically unstructured, or where the interacting region 
has been mapped to a disordered region of the structure. In 
this case, issues with misfolding proteins are less of a concern, 
and epPCR might be useful for identifying binding domains 
or other motifs of interest within these viral proteins.
From an RNA virus evolution perspective, whilst our epPCR 
library generation effectively mimics the mutations caused 
by an error prone viral RNA polymerase, and we can apply 
a bottleneck (in this case loss of functionality in a cell- cell 
fusion assay), we could not take advantage of ‘natural selec-
tion’ and ‘survival of the fittest’ since our mutants were 
plasmid- rather than virally- encoded. We did attempt to 
clone the H mutants into a lentiviral expression system to 
rescue libraries of H- encoding PPRV pseudotypes; however, 
the efficiency of morbillivirus pseudotyping was too low (data 
not shown). Another caveat of this approach is that a very 
low mass of DNA is needed to avoid the generation of mosaic 
pseudotypes, concerns that have been addressed elsewhere 
with more efficient packaging systems [20, 21].
To summarise, the application of epPCR to functionally char-
acterise a proposed functional domain within a viral protein, 
in this case PPRV H, provided a valuable set of mutations 
for downstream analysis. Combining this tool with a high 
throughput functional assay provides an effective mechanism 
for rapid characterisation of viral proteins.
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